Literature DB >> 10490955

Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.

K E Wilson1, Z Li, M Kara, K L Gardner, D D Roberts.   

Abstract

Cell-cell and cell-matrix interactions play important regulatory roles in lymphocyte homeostasis. Thrombospondin-1 (TSP1) is a matricellular protein that differentially promotes the adhesion of resting and activated T cells. In this work, we show that adhesion of Jurkat T cells on substrates coated with TSP1 or TSP1-derived peptides is mediated by beta 1 integrins, CD47, and heparan sulfate proteoglycans. Interactions with TSP1 or TSP1 peptides stimulated CD3-induced Ras activation and tyrosine phosphorylation of several T cell proteins. The signals from TSP1 and its derived peptides differentially synergized with activation of the TCR to induce phosphorylation of linker for activation of T cells (LAT) and extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase, and p38 kinases. The phosphorylation of ERK in the presence of full-length TSP1 was transient and dependent on a beta 1 integrin receptor. Interestingly, peptides derived from the type 1 repeats of TSP1 and a CD47-binding peptide from the carboxyl-terminal domain of TSP1 also stimulated mitogen-activated protein (MAP) kinase phosphorylation. Moreover, the TSP1 heparin-binding peptide synergized with Ab-ligated TCR to transduce signals to the nucleus, detected by activation of AP-1- and Elk-dependent transcription. This TSP1 peptide-dependent activation of AP-1 was inhibited by both heparin and the MAP/ERK kinase inhibitor PD98059, providing a functional link between adhesion molecule interaction and nuclear transactivation events via the MAP kinase pathways. These findings have implications for the role of extracellular TSP1 and TSP1 fragments in the regulation of T cell function during hemostasis, wound repair, and other inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490955

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.

Authors:  Sukhbir Kaur; Svetlana A Kuznetsova; Michael L Pendrak; John M Sipes; Martin J Romeo; Zhuqing Li; Lijuan Zhang; David D Roberts
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 3.  Signaling and stress: The redox landscape in NOS2 biology.

Authors:  Douglas D Thomas; Julie L Heinecke; Lisa A Ridnour; Robert Y Cheng; Aparna H Kesarwala; Christopher H Switzer; Daniel W McVicar; David D Roberts; Sharon Glynn; Jon M Fukuto; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

4.  sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration.

Authors:  Gema Martin-Manso; Maria J Calzada; Yoshiro Chuman; John M Sipes; Charles P Xavier; Vladimir Wolf; Svetlana A Kuznetsova; Jeffrey S Rubin; David D Roberts
Journal:  Arch Biochem Biophys       Date:  2011-03-21       Impact factor: 4.013

5.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

6.  Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus.

Authors:  Tuba Esfandyari; Ayalew Tefferi; Anna Szmidt; Tommy Alain; Pawel Zwolak; Terra Lasho; Patrick W Lee; Faris Farassati
Journal:  Mol Oncol       Date:  2009-07-28       Impact factor: 6.603

Review 7.  Intestinal epithelial CD98: an oligomeric and multifunctional protein.

Authors:  Yutao Yan; Sona Vasudevan; Hang Thi Thu Nguyen; Didier Merlin
Journal:  Biochim Biophys Acta       Date:  2008-06-24

Review 8.  Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.

Authors:  David R Soto-Pantoja; Erica V Stein; Natasha M Rogers; Maryam Sharifi-Sanjani; Jeffrey S Isenberg; David D Roberts
Journal:  Expert Opin Ther Targets       Date:  2012-10-27       Impact factor: 6.902

9.  Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.

Authors:  Hiroaki Kamijo; Tomomitsu Miyagaki; Naomi Takahashi-Shishido; Rina Nakajima; Tomonori Oka; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Leukemia       Date:  2019-11-11       Impact factor: 11.528

10.  TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly.

Authors:  Svetlana A Kuznetsova; David J Mahoney; Gema Martin-Manso; Tariq Ali; Hilke A Nentwich; John M Sipes; Bixi Zeng; Tikva Vogel; Anthony J Day; David D Roberts
Journal:  Matrix Biol       Date:  2007-10-25       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.